Seattle-based health tech nonprofit Audere on Wednesday announced it has named Dino Rech, a former executive at the Aurum Institute, as its new CEO.
Rech spent more than three years at Aurum, which focuses on the research and treatment of tuberculosis and HIV. He served for almost three years as a regional chief operating officer, after which he spent close to a year as the director of group strategy innovation and business development.
“Dr. Rech is tailor-made to bring Audere into its next phase as a company. His experience leading teams in the global health and digital health spaces will enable him to build upon Audere’s foundation as a research organization and evolve its operating model to maximize impact," Philip Su, founder of Audere, said in a statement.
Su has served as Audere's CEO since its founding in 2018. Su will continue as an adviser to the nonprofit as Rech steps into the CEO role. Rech started on Monday.
Rech founded the Centre for HIV and AIDS Prevention Studies (CHAPS), where he also served as CEO. The organization's HIV care reached more than 500,000 people during Rech's tenure. He was with CHAPS from 2010 to 2016, according to his LinkedIn.
Audere uses software "to improve global health in the world’s most underserved communities," according to its website. The nonprofit created a diagnostic aide to help with malaria testing, as well as specimen collection test kit for Covid-19.
Grants from both the Bill and Melinda Gates Foundation and Justworks fund Audere's work.
"Having dedicated my career to the advancement of global health through research and innovation, I am passionate about Audere’s mission to develop solutions that improve community health outcomes in low- and middle-income countries," Rech said in a statement.
